Caplight Directory>Companies>Appia Bio-preview>Appia-bio


Appia Bio

Appia Bio

Private
Culver City, CaliforniaHealthcare & Life Scienceshttps://www.appiabio.com

Last Round

Series A

May 11, 2021

Total Funding Raised

$52M

Momentum Score

25 /100

Company Overview

Appia Bio is a biotechnology company focused on developing chimeric antigen receptor-natural killer T (CAR-NKT) cell therapies for safe and targeted cancer treatments, utilizing advanced stem cell technology to provide allogeneic off-the-shelf solutions for physicians.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

allogeneic cell therapyoff-the-shelf cell therapyCAR-iNKT cellsACUA platformcancer immunotherapyallo cell therapyhematopoietic stem cellsHSCschimeric antigen receptorcell therapy platformCAR-gamma-delta T cellscell engineeringB-cell malignanciesblood cancerpreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Appia Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Appia Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 11, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Jeff Wiezorek

Founder, Chief Medical Officer

Founding Team

JeenJoo S Kang

Chief Executive Officer

Executive Team

Appia Bio Investors

Notable investors and investment history

InvestorRounds
California Institute of TechnologySeries A
Two Sigma VenturesSeries A
Freeflow VenturesSeed, Series A
8VCSeries A
Takeda VenturesSeries A
Sherpa Healthcare PartnersSeed, Series A
View all Investors

Appia Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Appia Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Appia Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCulver City, California
Employee Range16
Year Founded2020
Last FundingMay 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.